CVE-2019-13157

Published: Nov 22, 2019Modified: Nov 21, 2024

7.5

Vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N

Exploitability: 3.9 / Impact: 3.6

Source: NVD

Description

nsGreen.dll in Naver Vaccine 2.1.4 allows remote attackers to overwrite arbitary files via directory traversal sequences in a filename within nsz archive.

Affected (1)

Products: Naver: Vaccine

Naver

1 product

Vaccine

Configuration A

1 vulnerable

Vulnerable Software	Affected Versions
Naver Vaccine	Version 2.1.4

Related CWEs

CWE-22

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.

References (2)

https://cve.naver.com/detail/cve-2019-13157

Source: cve@navercorp.com

Vendor Advisory

https://cve.naver.com/detail/cve-2019-13157

Source: af854a3a-2127-422b-91ae-364da2661108

Vendor Advisory

Timeline

No history available yet.